Cidara Therapeutics, Inc.
CDTX
CDTX: Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Its other product candidates include CD377, CD388, RSV AVC, HIV AVC, and SARS-CoV-2 AVC.
moreShow CDTX Financials
Recent trades of CDTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CDTX's directors and management
Government lobbying spending instances
-
$10,000 Oct 19, 2020 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$20,000 Jul 15, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$20,000 Apr 16, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
New patents grants
-
Patent Title: Dosing regimens for treatment of fungal infections Aug. 01, 2023
-
Patent Title: Dosing regimens for echinocandin class compounds May. 23, 2023
-
Patent Title: Synthesis of echinocandin antifungal agent Dec. 13, 2022
-
Patent Title: Compositions and methods for the treatment of viral infections Nov. 29, 2022
-
Patent Title: Compositions and methods for the treatment of fungal infections Dec. 14, 2021
-
Patent Title: Methods for preventing and treating pneumocystis infections Sep. 22, 2020
-
Patent Title: Dosing regimens for echinocandin class compounds Jul. 07, 2020
-
Patent Title: Methods for preventing and treating pneumocystis infections Aug. 06, 2019
-
Patent Title: Dosing regimens for echinocandin class compounds Jul. 10, 2018
-
Patent Title: Antifungal agents and uses thereof Jun. 13, 2017
-
Patent Title: Dosing regimens for echinocandin class compounds Dec. 27, 2016
-
Patent Title: Antifungal agents and uses thereof Dec. 22, 2015
Federal grants, loans, and purchases
Followers on CDTX's company Twitter account
Number of mentions of CDTX in WallStreetBets Daily Discussion
Recent insights relating to CDTX
Recent picks made for CDTX stock on CNBC
ETFs with the largest estimated holdings in CDTX
Flights by private jets registered to CDTX